[{"address1": "Maxim 1", "address2": "2 Parklands Way Holytown", "city": "Motherwell", "zip": "ML1 4WR", "country": "United Kingdom", "phone": "44 14 1433 7557", "website": "https://tcbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bryan Leland Kobel", "age": 45, "title": "CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 544560, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin Edward Thorp", "age": 72, "title": "CFO & Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 410521, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Camarra", "title": "Executive Vice President of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lauren  Bor Ph.D.", "title": "Head of Commercial Development Division", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.46, "open": 2.21, "dayLow": 2.03, "dayHigh": 2.71, "regularMarketPreviousClose": 2.46, "regularMarketOpen": 2.21, "regularMarketDayLow": 2.03, "regularMarketDayHigh": 2.71, "beta": -0.145, "forwardPE": -0.5304348, "volume": 627188, "regularMarketVolume": 627188, "averageVolume": 186078, "averageVolume10days": 775620, "averageDailyVolume10Day": 775620, "bid": 2.35, "ask": 2.51, "bidSize": 300, "askSize": 300, "marketCap": 1251700, "fiftyTwoWeekLow": 2.03, "fiftyTwoWeekHigh": 654.0, "fiftyDayAverage": 9.1452, "twoHundredDayAverage": 101.8663, "currency": "USD", "enterpriseValue": 241974960, "floatShares": 98869384, "sharesOutstanding": 512992, "sharesShort": 3838, "sharesShortPriorMonth": 9069, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0075, "heldPercentInstitutions": 0.0070499997, "shortRatio": 0.08, "shortPercentOfFloat": 0.007900001, "impliedSharesOutstanding": 3195130, "bookValue": 81.056, "priceToBook": 0.030102646, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -11573336, "trailingEps": -4621.07, "forwardEps": -4.6, "lastSplitFactor": "1:20", "lastSplitDate": 1739145600, "enterpriseToEbitda": -21.362, "52WeekChange": -0.9893966, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TCBP", "underlyingSymbol": "TCBP", "shortName": "TC BioPharm (Holdings) plc", "longName": "TC Biopharm (Holdings) Plc", "firstTradeDateEpochUtc": 1644589800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ef544858-646b-3e8d-bcb0-2aed3539a593", "messageBoardId": "finmb_1681274131", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.44, "targetHighPrice": 48.0, "targetLowPrice": 48.0, "targetMeanPrice": 48.0, "targetMedianPrice": 48.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1004329, "totalCashPerShare": 0.01, "ebitda": -11327400, "totalDebt": 1653527, "quickRatio": 0.642, "currentRatio": 1.12, "debtToEquity": 82.504, "returnOnAssets": -0.98203003, "returnOnEquity": -5.77043, "freeCashflow": -6030418, "operatingCashflow": -8837196, "financialCurrency": "GBP", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]